Dr. Zafia Anklesaria

Media Releases

Get to know Pulmonologist and Critical Care Specialist Dr. Zafia Anklesaria, who serves the population of Los Angeles, California. Dr. Anklesaria completed her undergraduate degree from the University of North Carolina at Chapel Hill in 2006. Wanting to further her education she then completed her Medical Degree from the Thomas Jefferson University in 2012, giving her over 7 years of experience in her field. After obtaining her Medical Degree she completed her Internal Medicine and Pulmonary residency with the University of California. Dr. Anklesaria is certified in Pulmonary Care by the American Board of Internal Medicine. To stay up to date in her field she remains a professional member of the APS Foundation of America Inc., and the American College-Chest Physicians. She currently practices with VEP Healthcare, Inc where she focuses primarily on critical care and secondary on pulmonary care. When not working, she enjoys riding horses. Critical care medicine encompasses the diagnosis and treatment of a wide variety of clinical problems representing the extreme of human disease. Critically ill patients require intensive care by a coordinated team. The critical care specialist (sometimes referred to as an “intensivist”) may be the primary provider of care or a consultant. The intensivist needs to be competent not only in a broad range of conditions common among critically ill patients but also with the technological procedures and devices used in intensive care settings. The care of critically ill patients also raises many complicated ethical and social issues, and the intensivist must be competent in areas such as end-of-life decisions, advance directives, estimating prognosis, and counseling of patients and their families.

Recommended Articles

• Procedure Found to Help Children with Cystic Fibrosis

  Researchers have recently found that the simple procedure of inhaling hypertonic saline solution, or HSS, can increase sputum production and improve pathogen identification in children. This breakthrough will act as a benefit to many suffering from cystic fibrosis who are unable to spontaneously...

• Differentiating Croup from Asthma

  Croup and asthma are two conditions that involve organs, which are responsible for breathing. Since both conditions affect the respiratory system, it is highly advisable to learn their differences to be able to approach each condition properly.What Is Croup?Croup is typically caused by a virus. It...

• Groundbreaking Triple-Therapy Could Be on the Horizon for Cystic Fibrosis

  Researchers work around the clock and the world to find new discoveries in terms of cystic fibrosis treatment. Thanks to foundations, donations, and ongoing research, cystic fibrosis has made leaps and bounds as far as treatment is concerned. There is one pharmaceutical company at the forefront of...

• How Astrophysics Could Transform the Treatment of Cystic Fibrosis and Other Rare Diseases

  Cystic fibrosis is a genetic disease that mainly affects the lungs, liver, pancreas, intestines, reproductive organs, and sinuses. It causes thick and sticky mucus to accumulate and clog the lungs, making it difficult to breathe and resulting in persistent lung infections and lung damage. The...

• The Link Between Childhood Asthma and COPD

  It is clear that smoking is one of the greatest risks for chronic obstructive pulmonary disease (COPD); however, there are other factors, such as second hand smoking (wherein you get the effects of smoking by getting exposed to it even if you do not smoke), contact with pollution, genetic...

• Antibiotics for Cystic Fibrosis

  Cystic fibrosis damages the lungs, digestive system, and other organs in the body. It affects the cells producing mucus, sweat, and digestive juices. It is caused due to defect in a gene. This gene changes a protein responsible for movement of salts in and out of cells. As a result, thick, sticky...